Advertisement

Topics

Chugai Pharma Europe Ltd Company Profile

16:51 EST 18th December 2018 | BioPortfolio

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic antibody biotechnology through over-the-counter medicines to consumer healthcare products.
Chugai is currently the 5th ranked pharmaceutical company in Japan in terms of sales, (the world’s second largest pharmaceutical market after the USA).
On 1st October 2002, Chugai Pharmaceutical Co became a member of the Roche Group, and is Roche’s sole representative in Japan following the integration of Nippon Roche and Chugai.
One of the first examples of specific collaboration between Chugai and Roche is that of MRA: Chugai’s monoclonal antibody in development for the treatment of a number of conditions (eg Rheumatoid Arthritis).
Chugai conducts research at its Japanese research sites employing cutting-edge techniques for identification of small molecule and biological therapeutic candidates.

Location

Mulliner House
Turnham Green
London
W4 1NN
United Kingdom

Contact

Phone: 44 (0) 20 8987 5600
Fax: 44 (0) 20 8987 5660
Email: info@chugai-pharm.co.uk


News Articles [645 Associated News Articles listed on BioPortfolio]

Results of Global Phase III Study with Chugai's HEMLIBRA® for Hemophilia A Without Inhibitors ...

For MediaChugai Pharmaceutical Co., Ltd.Media Relations Group, Corporate Communications Dept.,Tomoko ShimizuTel: +81-3-3273-0881E-mail: pr@chugai-pharm.co.jp***For US mediaChugai ...

Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront

Eli Lilly just signed a license deal with Tokyo’s Chugai Pharmaceutical Co. for OWL833, Chugai’s oral non-peptidic GLP-1 receptor agonist. It is Phase 1-ready being evaluated for type 2 diabetes.

Chugai Pharma Europe appoints Troy Robinson as Managing Director of UK business

Announcement of Business Expansion of Chugai Pharmabody Research Pte. Ltd., Chugai’s Research Subsidiary

TOKYO–(BUSINESS WIRE)–#antibody—Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that it has decided to expand the business of Chugai Pharmabody Research Pte. Ltd. (herei...

#news #biotech Eli Lilly nets an early-stage GLP-1 diabetes drug from Chugai for $50M

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly nets an early-stage GLP-1 diabetes drug from Chugai for $50M .Eli L...

Chugai Pharmaceutical to expand Singaporean research subsidiary

Japan-based Chugai Pharmaceutical has revealed plans to expand its research subsidiary in Singapore, Chugai Pharmabody Research (CPR), in order to...Read More... The post Chugai Pharmaceutical to expa...

Chugai's HEMLIBRA® Approved in Taiwan for the Treatment of Hemophilia A with Factor VIII Inhibitors

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug ...

Roche-Tochter Chugai geht Lizenzvereinbarung mit Roche für Entrectinib ein

Wie der japanische Pharmakonzern am Dienstag mitteilt, erhält Chugai im Zuge der Vereinbarung die exklusiven Rechte, den Kandidaten in Japan zu entwickeln und zu vermarkten. Dafür werde man eine ei....

Drugs and Medications [246 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [363 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Towards the risk of Yellow Fever transmission in Europe.

Yellow fever (YF) is an emerging expanding fatal arboviral disease that has been imported at least six times in Europe during the first half of 2018, while only seven travel-associated YF cases have b...

Clinical trials go virtual, big pharma dives in.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

The removal of DAA restrictions in Europe - one step closer to eliminating HCV as a major public health threat.

Of ∼10.2 million people with chronic HCV infection in Europe, most are living in Eastern Europe (6.7 million) followed by Western Europe (2.3 million) and Central Europe (1.2 million). HCV transmiss...

Clinical Trials [708 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

OK432 (Picibanil) in the Treatment of Lymphatic Malformations

Standard of care for Lymphatic Malformations has been surgical excision. We have been using OK432/Picibanil (generously supplied by Chugai Pharmaceuticals in Japan) since 1992 with great s...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [1614 Associated Companies listed on BioPortfolio]

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...

Chugai Pharma USA, Inc.

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

More Information about "Chugai Pharma Europe Ltd" on BioPortfolio

We have published hundreds of Chugai Pharma Europe Ltd news stories on BioPortfolio along with dozens of Chugai Pharma Europe Ltd Clinical Trials and PubMed Articles about Chugai Pharma Europe Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharma Europe Ltd Companies in our database. You can also find out about relevant Chugai Pharma Europe Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record